The global vaccine alliance is facing a major setback following major funding cuts, most notably from the US. Simon Williams asks how the world9s largest funder of vaccines for low and middle income countries will survive in the Trump era
Simon Williams (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: